An interventional study of NDT Gait Training System in Stroke, sponsored by Cheng-Hsin General Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2026-02-09.
Sponsored by Cheng-Hsin General Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 394 studies in Stroke with a site in Taiwan — 73 open to participants now, 82 under way, 4 of them phase 3. Stroke · Taiwan.
Among the 394 studies in Stroke with a site in Taiwan, this one is the 207th largest by planned enrollment of the 337 interventional ones that give a count, is one of 24 that started in 2024, is one of 261 with no phase, reaches primary completion later than 8 of the 81 other live ones, and was the 368th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →73 of the 394 studies in Stroke with a site in Taiwan are open now. Recruiting first, the newest first:
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20–80
National Cheng-Kung University Hospital · Sites in Taiwan
Ages 20–80 · Healthy volunteers
Chimei Medical Center · Sites in Taiwan
Ages 65–90
I-Shou University · Sites in Taiwan
Ages 20–80
Eli Lilly and Company · Sites in Taiwan, Argentina, Australia and 35 more countries
Ages 50+
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 20 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
394 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 17 · Phase 2 26 · Phase 3 37 · Phase 4 5
First in 1998; this study’s year is marked. 24 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 54 across the 337 interventional studies, 100 across the 56 observational. Of the 207 that completed or were terminated, 15 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
36 of 394 have an industry lead sponsor. The 10 most frequent:
Cheng-Hsin General Hospital is the lead sponsor of 24 studies on the registry; 8 are open to participants now.
Cheng-Hsin General Hospital has 4 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
20 of the studies in Stroke with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06204744Chang Gung Memorial HospitalHome-based Arm and Hand Exercise Program for Stroke: A Multisite Trial | 2026-12 |
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
| NCT04874454National Taiwan University HospitalEvaluating Potential Risk of Choking by Laryngeal Ultrasound in Patients With Acute Stroke | 2026-12-31 |
| NCT07620210Chimei Medical CenterEffects of CTAR and a Swallowing Pressure Ball in Older Stroke Adults | 2026-12-31 |
| NCT06883357National Taiwan University HospitalThe Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke. | 2026-12-31 |
Add all 20 to your calendar (.ics) → With an account.
Among the 394 studies in Stroke with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the effectiveness of a novel mobile neurodevelopmental treatment (NDT) gait training device for patients recovering from stroke. Stroke is a major cause of disability worldwide, and many survivors experience difficulty with walking and require long-term rehabilitation. NDT is a widely used rehabilitation approach that focuses on improving motor control through techniques such as facilitation, inhibition, and key point control. However, traditional NDT gait training can be physically demanding for therapists and often limits the training intensity and duration for patients.
To address these challenges, this study introduces an automated NDT gait training device that replicates therapist techniques using mechanical support and sensory feedback. The system uses bilateral dynamic assistance at the waist, auditory cues, and wearable inertial measurement units (IMUs) to help patients practice natural and symmetric walking patterns on the ground, instead of being restricted to treadmill training. The IMUs also provide objective gait data to assess improvement in gait symmetry, pelvic rotation, walking speed, and cadence.
The primary goal is to assess changes in these gait parameters before and after NDT-based intervention. The study plans to enroll 40 adult stroke survivors (aged 20 and older) over a 3-year period starting from May 1, 2024.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
NDT gait trainer which can automatically repeat NDT intervention, thereby alleviating therapists' workload and extending patients' training time. They analyzed therapists' intervention in manual NDT training and concluded that therapists cued subjects' anterior superior iliac spines (ASISs) when perceiving opposite heel strikes (HSs).
Device: NDT Gait Training System
The intervention includes a NDT gait training device that mimics therapist techniques through mechanical assistance, synchronized with auditory feedback and real-time gait analysis using IMU sensors.
Pelvic rotation
The gait parameter will be collected using wearable inertial measurement units (IMUs) before and after the NDT gait training intervention and pelvic rotation will be measured through axial angular velocity
Time frame: Baseline (pre-intervention) and post-intervention (immediately after completion of the NDT gait training program).
Walking speed
Walking speed will be estimated from IMU during walking and reported in meters per second (m/s).
Time frame: Baseline (pre-intervention) and post-intervention (immediately after completion of the NDT gait training program).
Step length
Step length will be derived from IMU-based spatiotemporal gait data collected during overground walking and reported in meters (m).
Time frame: Baseline (pre-intervention) and post-intervention (immediately after completion of the NDT gait training intervention).
Plan to share: No
No publications or documents are linked to this record.
Ran from May 2024 to primary completion in Dec 2024, 7 months.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 7 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cheng-Hsin General Hospital